Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by emmitfitzhumeon Feb 23, 2023 7:29pm
81 Views
Post# 35302317

RE:Some shareholders...

RE:Some shareholders...Agree JD.

I am guilty of a rather apathetic presence on the board as of late, not for lack of interest, just have been communicating via other channels.

I too am somewhat flummoxed by the outcome of the vote, would like to see the count, as I and others I am aware of certainly voted out the board and against the arrangement, I personally didn't see any other choice.  The board and CEO have objectively failed, for me, it is not personal.

I have no reason to believe that XB3 does not work unless I am being lied to.  It would seem a tragedy if Bioasis ends this way assuming nothing has changed with the science, and I think a group of likeminded shareholder could put together some sort of syndicate to keep this entity from defaulting to Lind.  Obviously that would take some money and some willingness from shareholders to back this entity.  I and others have been speaking about this possibility offline and am happy to discuss further with anyone interested.  Feel free to DM me.

Still very much here.  

<< Previous
Bullboard Posts
Next >>